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INVESTIGATIVE REPORT
Lower vitamin D serum levels are linked to increased 
melanoma risk and poorer survival. Naevus counts are 
associated with both melanoma risk and survival and 
to leucocyte telomere length. Vitamin D is also linked 
to telomere biology with higher levels of vitamin D in 
individuals with longer leucocyte telomere length de-
spite adjusting for age. Using the TwinsUK data, we 
explored the association between naevus count, leu-
cocyte telomere length and vitamin D serum levels. 
Increasing vitamin D levels were associated with in-
creasing naevus count: serum levels were 73.3 nmol/l 
in individuals with less than 50 naevi compared to 
78.8 nmol/l in individuals with more than 50 naevi 
(p = 0.002). In the final regression model, using nae-
vus count as a continuous variable, vitamin D remai-
ned associated with higher naevus counts despite ad-
justment for age, weight, height, season of sampling 
and twin relatedness (p = 0.02). Further adjustment 
for leucocyte telomere length, decreased the magni-
tude of the association but  it remained significant so 
leucocyte telomere length is not the sole driver of this 
association. Having large numbers of naevi is associa-
ted with higher vitamin D serum levels.
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Higher vitamin D (25(OH)D) levels have been shown to protect from melanoma and furthermore from 
melanoma recurrence (1). It is unclear whether 25(OH)
D serum levels are protective per se, or, are a proxy 
marker for other protective factors in melanoma (2). It is 
possible that higher 25(OH)D is a reflection of healthier 
lifestyle which in turns confer some protection against 
cancer in general (3).
Twin studies have shown that naevus number is an 
heritable trait (4) and GWA studies for melanoma and 
naevus counts have identified many SNPs explaining 
the genetic variation associated both with naevi number 
and melanoma risk (5–7). Naevus counts decrease with 
age. High naevus counts are also associated with longer 
leucocyte telomere length (LTL) despite adjusting for 
age which suggests that naevi number and size and 
senescence are linked (8).
Mounting evidence suggests that, in addition to its well 
described roles in skin, bone, and muscle physiology 
(9), 25(OH)D acts as an inhibitor of the inflammatory 
response through several pathways. The inhibitory effect 
of vitamin D on the inflammatory response (10) also 
leads to a potential link between this vitamin and LTL 
biology (11), suggesting a potential role of 25(OH)D in 
senescence (12). The relationship between vitamin D 
and melanoma is quite complex as many possible con-
founders may affect the significance of the association. It 
has been shown that both melanoma risk and melanoma 
recurrence may be increased in those with low Vitamin D 
(13–15). The aim of this study was to look at the associa-
tions between number of naevi (the strongest melanoma 
risk factor) and 25(OH)D serum levels.
METHODS
Ethics Committee approval for this study was obtained from the 
Guy’s and St Thomas Hospital NHS Trust, London. Subjects were 
not aware of the hypotheses being tested as they were part of a large 
study investigating many age-related diseases and traits for which 
informed written consent was obtained (www. twinsuk.ac.uk).
Three thousand five hundred and one consecutive women were 
recruited from the Twins UK Adult Twin Registry in London 
(wwww.twinsuk.ac.uk) between January 1995 and December 
2003. The twins involved in this study have previously been shown 
to be representative of the UK singleton population in general 
(16). All were adult females aged between 18 and 79 years of age.
Skin data
The validated protocol for naevus counts has previously been 
published elsewhere (17). In particular, a naevus was defined as 
a melanocytic lesion ≥ 2 mm in diameter to avoid any confusion 
with ephelides. Skin type was assessed according to the Fitzpatrick 
classification. 
Vitamin D 
Total 25(OH)D levels were measured by radioimmunoassay 
using Diasorin RIA kit (Diasorin, Minnesota, USA) as previously 
described (10).
Leucocyte telomere length
DNA was extracted from isolated leukocytes after an overnight 
fast and the mean leukocyte terminal restriction fragment length 
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(LTL) was measured using the Southern blot method as described 
previously (18). The laboratory conducting the LTL measurements 
was blinded to all characteristics of the white cell donors. 
Statistics
All statistical analyses were performed using the Stata statistical 
software (Stata 12 Corp, USA). The covariates included height, 
weight, season of 25(OH)D measurement, LTL (as reflecting the 
chronological age), age and skin type according to Fitzpatrick. 
BMI is usually reported as a covariate to adjust for 25(OH)D 
level, but we preferred to include height and weight separately as 
height has been previously associated with naevi, while weight 
was not (19). 
Associations between 25(OH)D levels and skin type, age, season 
of sampling, height and weight were investigated using Pearson 
correlations and linear regressions. For categorical data, chi square 
test was used. Logistic regression was used for calculating risk 
of low 25(OH)D serum levels in relation to skin type and with 
adjustments for age and season of sampling. Multicollinearity 
between variables was tested with the variance inflation factor, 
without significant results. All analyses were adjusted for the 
fact that the twin pairs were related using the command cluster in 
logistic regressions. Model selection was carried out by using the 
Bayesian Information Criterion, in which the potential confounders 
were analysed by assessing the top 10 models as generated by the 
Bayesian Information Criterion. The resultant linear regression 
residual plots were checked for violations of linear relations. 
RESULTS
Three thousand five hundred and one Caucasian women 
have been included in the study. Mean age of volunteers 
was 46.5 years (range 18–79). Mean 25(OH)D levels 
was 75 nmol/l (median 68 nmol/l, range 5–300). 25(OH)
D levels were influenced by season of blood sampling 
(r = 0.34 p < 0.0001): mean 25(OH)D level during the 
spring and summer months was 85.2 nmol/l compared to 
65.4 nmol/l in the autumn and winter months (p < 0.001). 
Mean ± SD height was 163 ± 7 cm and was not correlated 
with 25(OH)D (beta 0.07, p = 0.50). Mean ± SD weight 
was 67.5 ± 12.9 kg and was inversely correlated with 
25(OH)D (beta –0.35, p < 0.001). 25(OH)D levels de-
creased with age (coeff –0.15, p = 0.04).
There was a positive association between LTL and 
season adjusted 25(OH)D, when adjusting for height, 
weight and age (beta 2.48, p = 0.013). There was a posi-
tive association between skin type and 25(OH)D, with 
higher levels in skin type 3/4 compared to skin type 1/2 
(beta 3.96, p = 0.017) when adjusted for season and age 
at time of sampling.
Naevi count were negatively associated with age (beta 
–0.52, p < 0.001) even after adjustments for height and 
weight. Mean total naevus count was 32 (range 0–298). 
Age-adjusted naevus count was positively associated to 
season-adjusted 25(OH)D (beta = 0.04, p = 0.02). Mean 
25(OH)D was 73.3 nmol/l in twins with less than 50 
naevi compared to 78.8 nmol/l (p = 0.002) in those with 
50 or more naevi. This association between naevi and 
season-adjusted 25(OH)D was maintained even after 
adjustments for age, height, weight, season of sampling 
and skin type (beta = 0.056 p = 0.009) (Table I). Further-
more, the positive association between naevus count 
and 25 (OH)D was maintained even after adjusting for 
age-adjusted LTL with a slight decrease in the strength 
of the association (beta = 0.050 p = 0.036) (Table I). 
DISCUSSION
High numbers of naevi is one of the most powerful risk 
factor for melanoma which suggests a lack of senes-
cence in melanocytes of individuals at high risk (4). We 
report, for the first time, a positive correlation between 
the number of naevi and serum levels of 25(OH)D after 
adjustment for age, weight, height, season of sampling 
and twin relatedness. 
The association between skin type and 25(OH)D pre-
viously published using the TwinsUK dataset showed that 
lower levels of vitamin D are found in skin type I and 
II compared to skin type III and IV (20). However, our 
analyses on the association between 25(OH)D and naevi 
are adjusted for skin type. If skin type was a confoun-
der, it would act the other way round as lower 25(OH)
D levels would have been expected in fairer individuals 
who usually have more naevi (21) but the reverse was 
found with higher naevus counts associated with higher 
vitamin D levels, so skin type is unlikely to be a factor 
driving this association. 
Melanoma and high naevus counts have been linked 
to longer LTL. 25(OH)D serum levels have also been 
reported to be an index of ageing as the levels decrease 
with age (10) so our findings of higher 25(OH)D in 
subjects at higher risk of melanoma supports the notion 
that the biological age of individuals with high naevus 
count might be younger than their chronological age, in 
line with their longer LTL and higher 25(OH)D levels. 
LTL was likely to play a role in the 25(OH)D-naevus 
count association reported here, as naevi count have pre-
viously been linked to longer LTL (8). However, despite 
adjusting for LTL, the association between naevi counts 
and 25(OH)D remained, so LTL does not fully drive the 
correlation and other factors must be involved. 
A number of cohort studies have addressed a possible 
protective effect of 25(OH)D on melanoma risk (15). 
Table I. Linear model for the association between 25(OH)
D and naevus count, height, weight, skin type and further 
adjustment for leucocyte telomere length (LTL)
25(OH)D Beta SE p CI
Naevus count 0.05 0.02 0.04 0.002 –0.10
Height 0.32 0.17 0.06 –0.01 –0.65
Weight –0.28 0.06 < 0.001 –0.41 –0.14
LTL 2.51 0.99 0.011 0.57 –4.46
Skin type 4.44 1.01 < 0.001 2.50 6.49
Robust analyses adjusted for season of sampling and age, when the LTL is removed 
from the model the global estimation of the variables does not change significantly. 
In particular for naevus count the beta estimation was 0.056 (CI 0.014–0.098).
SE: standard error; CI: confidence interval.
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Despite this, no association has been reported between 
25(OH)D supplementation and melanoma risk (22). It 
is therefore possible that higher 25(OH)D serum levels 
are proxy for other environmental and/or genetic factors 
which may impact on melanoma risk but not 25(OH)D 
intake alone. The fact that this study found a positive as-
sociation between naevus count and higher vitamin D and 
that high naevus count confer a higher risk of melanoma 
may be seen as not supporting results of previous studies 
reporting a higher risk of melanoma with lower vitamin 
D levels (3). However, melanomas in individuals with 
low vitamin D (more likely to be older, with skin type 
1 or 2 with thicker melanoma tumours) are likely to be 
quite different from melanomas associated with high 
naevus counts which affect younger individuals and are 
associated with thinner melanomas more often of the 
superficial melanoma type (14). So it is important to 
separate melanomas associated with high naevus counts 
from those with low naevus counts as the divergent mela-
noma pathways in terms of phenotypic risk factors have 
already been well described (23). High naevus counts 
whilst increasing melanoma risk, have also been found to 
offer survival advantage after adjusting for all melanoma 
prognostic factors (24). The same prognostic value was 
also maintained in positive sentinel lymph node (SLN) 
patients (stage III), who have usually worse prognosis 
(24–26). The association between 25(OH)D levels and 
improved melanoma survival (lower Breslow thickness 
and less ulceration) has been reported before in large stu-
dies (10, 14). SNPs determining 25(OH)D serum levels, 
have not yet been linked to melanoma prognosis or to 
melanoma prognostic factors such as Breslow thickness, 
ulceration or mitosis but sample size may be an issue 
for some of these studies. So it is possible that previous 
reports of vitamin D being protective in melanoma re-
currence and death may be, in part, driven by LTL and 
naevus counts but this needs to be confirmed. 
A limitation of the TwinsUK study is that all subjects 
were females. For historical reasons, the Twin Research 
Unit recruited mostly females. Despite this, the analyses 
are unlikely to be affected, as there are no reported ef-
fects of sex on 25(OH)D levels (27) as well as significant 
gender effects on total body naevus count and on its 
distribution (28, 29).
We have demonstrated that naevus count should be 
taken in consideration when looking at the association 
between 25(OH)D serum levels and melanoma risk. Telo-
mere length, in part, influences the association between 
vitamin D levels and naevus counts. Other than LTL, 
other drivers for this association remain to be established 
but as vitamin D serum levels are linked to so many other 
phenotypes associated with to “better health” we would 
only speculate about what these factors could be. Further 
work is needed to investigate the protective role of vita-
min D in melanoma and other malignancies and whether 
it acts as a proxy for other phenotypes. Future vitamin 
D studies in melanoma should look at different subtypes 
of melanomas separately (superficial spreading versus 
nodular melanoma, high versus low naevus counts) and 
the effects of the host phenotype such as skin type and 
sun exposure need to be explored further. Evidence is 
lacking that recommending vitamin D supplementation 
is effective in reducing cancer risk and mortality, so 
potential genetics and environmental factors (apart from 
sun exposure) which drive higher vitamin D levels need 
to be better understood. 
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